Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled.

Sodium glucose co-transporter-2 inhibitors are a foundational therapy for the management of chronic heart failure (HF). The purpose of this study was to investigate whether the efficacy of sodium glucose co-transporter-2 inhibitors in patients with HF is maintained in patients with a history of coronary revascularization.